Elekta AB (publ) (EKTAY) Stock

About Elekta AB (publ)

Elekta AB (publ) is a global medical technology company dedicated to developing and delivering advanced clinical solutions for the treatment of cancer and brain disorders. Its comprehensive portfolio includes innovative radiotherapy systems such as the Elekta Unity MR-Linac, the Elekta Harmony linear accelerator, Elekta Infinity for diverse patient radiotherapy requirements, and the Elekta Synergy digital accelerator for advanced image-guided radiation therapy. Specific solutions like Versa HD are available for managing brain metastases. The company also supplies crucial treatment management software, automated and integrated quality assurance tools, and hardware and software for motion management. Further augmenting its oncology offerings, Elekta provides MOSAIQ Plaza for integrated multidisciplinary cancer care and Elekta Axis Cloud for managed hosting. Within brachytherapy, key products include the image-guided Elekta Studio, the mobile ImagingRing CT scanner, Oncentra Brachy for streamlining repetitive tasks, the Elekta Flexitron afterloader for precise workflow execution, and specialized applicators like Venezia and Geneva for cervical cancer treatment. For neurological conditions, Elekta offers a suite of advanced radiosurgery and neurosurgery solutions. This includes the Leksell Gamma Knife series – Icon for personalized radiation treatment, Perfexion for neurosurgical applications, and Lightning for accelerated procedures. Its neurosurgery product line features the Leksell Vantage Stereotactic System for intracranial interventions and the Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. Founded in 1972, Elekta maintains its corporate headquarters in Stockholm, Sweden.

Elekta AB (publ) is headquartered in SE.

Elekta AB (publ) (EKTAY) stock trades at $4.75 with a market capitalization of $1.81B. The stock is valued at a price-to-earnings (P/E) ratio of -34.36, price-to-book of 2.51, price-to-sales of 1.02. Over the past 52 weeks the stock has ranged between $4.35 and $6.93, and currently trades 31.5% below its 52-week high. It pays a dividend yielding 5.47%.

On profitability, Elekta AB (publ) generates a return on equity (ROE) of -6.37%, return on capital employed of 7.44%, an operating margin of 5.29%, a net profit margin of -3.10%.

Official website: www.elekta.com